Assessing Mumps Outbreak Risk in Highly Vaccinated Populations Using Spatial Seroprevalence Data

作者: Steven Abrams , Philippe Beutels , Niel Hens

DOI: 10.1093/AJE/KWU014

关键词: Incidence (epidemiology)OutbreakImmunityVirologyDiseaseVaccinationSerologyEnvironmental healthSeroprevalenceVaccine failureMedicine

摘要: Mumps is a potentially severe viral infection. The incidence of mumps has declined dramatically in high-income countries since the introduction antigen-containing vaccines. However, recent large outbreaks highly vaccinated populations suggest waning vaccine-induced immunity and primary vaccine failure. In this paper we present simple method for identifying geographic regions with high outbreak potential, demonstrated using 2006 seroprevalence data from Belgium Belgian vaccination coverage data. Predictions potential terms effective reproduction number future years signal an increased risk new outbreaks. Literature reviews on serological information both failure provide essential our predictions. Tailor-made additional campaigns would be valuable decreasing local pockets susceptibility, thereby reducing large-scale disease outbreaks; number; mumps; next-generation operator; serology; social contact hypothesis; coverage; vaccines

参考文章(82)
Jackson Je, Ehrenkranz Nj, Medler Em, Ventura Ak, Kenny Mt, Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Bulletin of The World Health Organization. ,vol. 52, pp. 81- 85 ,(1975)
H L Bock, K Stehr, B Stück, Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age. Asian Pacific Journal of Allergy and Immunology. ,vol. 20, pp. 113- 120 ,(2002)
Stanley A. Plotkin, Commentary: Mumps vaccines: do we need a new one? Pediatric Infectious Disease Journal. ,vol. 32, pp. 381- 382 ,(2013) , 10.1097/INF.0B013E3182809DDA
Leslie Ann Mitchell, Aubrey J. Tingle, Diane Décarie, Carol Lajeunesse, Serologic Responses to Measles, Mumps, and Rubella (MMR) Vaccine in Healthy Infants: Failure to Respond to Measles and Mumps Components May Influence Decisions on Timing of the Second Dose of MMR Canadian Journal of Public Health-revue Canadienne De Sante Publique. ,vol. 89, pp. 325- 328 ,(1998) , 10.1007/BF03404484
Robert M. May, Roy M. Anderson, Infectious Diseases of Humans: Dynamics and Control ,(1991)
V Hutse, M Sabbe, P Goubau, D Hue, Measles resurgence in Belgium from January to mid-April 2011: A preliminary report Eurosurveillance. ,vol. 16, pp. 19848- ,(2011) , 10.2807/ESE.16.16.19848-EN
A. Kraigher, A. M. Galazka, S. E. Robertson, Mumps and mumps vaccine: a global review. Bulletin of The World Health Organization. ,vol. 77, pp. 3- 14 ,(1999)
Hyunju Lee, Han Wool Kim, Hye Kyung Cho, Eun Ae Park, Kyong Min Choi, Kyung-Hyo Kim, Reappraisal of MMR vaccines currently used in Korea Pediatrics International. ,vol. 53, pp. 374- 380 ,(2011) , 10.1111/J.1442-200X.2010.03244.X